SEC Filings

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Filing date Form Description View
4

Statement of changes in beneficial ownership of securities

View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
3/A

An amendment to a 3 filing. Non-EDGAR filing

View HTML
3/A

An amendment to a 3 filing. Non-EDGAR filing

View HTML
3/A

An amendment to a 3 filing. Non-EDGAR filing

View HTML
3/A

An amendment to a 3 filing. Non-EDGAR filing

View HTML
3/A

An amendment to a 3 filing. Non-EDGAR filing

View HTML
3/A

An amendment to a 3 filing. Non-EDGAR filing

View HTML
3

Initial filing by director officer or owner of more than ten percent.

View HTML
3

Initial filing by director officer or owner of more than ten percent.

View HTML

Copyright Morningstar